<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37058170</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0533</ISSN><JournalIssue CitedMedium="Internet"><Volume>145</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Acta neuropathologica</Title><ISOAbbreviation>Acta Neuropathol</ISOAbbreviation></Journal><ArticleTitle>Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>773</StartPage><EndPage>791</EndPage><MedlinePgn>773-791</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00401-023-02569-x</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is associated with impaired energy metabolism, including weight loss and decreased appetite which are negatively correlated with survival. Neural mechanisms underlying metabolic impairment in ALS remain unknown. ALS patients and presymptomatic gene carriers have early hypothalamic atrophy. The lateral hypothalamic area (LHA) controls metabolic homeostasis through the secretion of neuropeptides such as orexin/hypocretin and melanin-concentrating hormone (MCH). Here, we show loss of MCH-positive neurons in three mouse models of ALS based on SOD1 or FUS mutations. Supplementation with MCH (1.2&#xa0;&#xb5;g/d) through continuous intracerebroventricular delivery led to weight gain in male mutant Sod1<sup>G86R</sup> mice. MCH supplementation increased food intake, rescued expression of the key appetite-related neuropeptide AgRP (agouti-related protein) and modified respiratory exchange ratio, suggesting increased carbohydrate usage during the inactive phase. Importantly, we document pTDP-43 pathology and neurodegeneration in the LHA of sporadic ALS patients. Neuronal cell loss was associated with pTDP-43-positive inclusions and signs of neurodegeneration in MCH-positive neurons. These results suggest that hypothalamic MCH is lost in ALS and contributes to the metabolic changes, including weight loss and decreased appetite.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bolborea</LastName><ForeName>Matei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, INSERM, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, UMR-S1118, Strasbourg, France. mbolborea@unistra.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life Sciences, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK. mbolborea@unistra.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vercruysse</LastName><ForeName>Pauline</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, INSERM, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, UMR-S1118, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daria</LastName><ForeName>Tselmen</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Clinical Neuroanatomy Section, Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reiners</LastName><ForeName>Johanna C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Clinical Neuroanatomy Section, Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Neurobiochemistry, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alami</LastName><ForeName>Najwa Ouali</ForeName><Initials>NO</Initials><AffiliationInfo><Affiliation>Clinical Neuroanatomy Section, Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guillot</LastName><ForeName>Simon J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, INSERM, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, UMR-S1118, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dieterl&#xe9;</LastName><ForeName>St&#xe9;phane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, INSERM, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, UMR-S1118, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinniger</LastName><ForeName>J&#xe9;r&#xf4;me</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, INSERM, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, UMR-S1118, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scekic-Zahirovic</LastName><ForeName>Jelena</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neurology Clinic, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory for Neuropathology, Institute for Pathology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Londo</LastName><ForeName>Amela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neurology Clinic, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory for Neuropathology, Institute for Pathology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arcay</LastName><ForeName>Hippolyte</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, INSERM, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, UMR-S1118, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goy</LastName><ForeName>Marc-Antoine</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, INSERM, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, UMR-S1118, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Tapia</LastName><ForeName>Claudia Nelson</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, INSERM, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, UMR-S1118, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thal</LastName><ForeName>Dietmar R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Laboratory for Neuropathology, Institute for Pathology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory for Neuropathology, Department of Imaging and Pathology, and Leuven Brain Institute, KU louvain, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, UZ Leuven, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibuya</LastName><ForeName>Kazumoto</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Chiba University School of Medicine, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otani</LastName><ForeName>Ryo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Chiba University School of Medicine, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arai</LastName><ForeName>Kimihito</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Chiba University School of Medicine, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuwabara</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Chiba University School of Medicine, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludolph</LastName><ForeName>Albert C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neurology Clinic, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE), Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roselli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neurology Clinic, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE), Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yilmazer-Hanke</LastName><ForeName>Deniz</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-1483-0286</Identifier><AffiliationInfo><Affiliation>Clinical Neuroanatomy Section, Department of Neurology, Ulm University, Ulm, Germany. deniz.yilmazer-hanke@uni-ulm.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Dupuis</LastName><ForeName>Luc</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-0902-5824</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, INSERM, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, UMR-S1118, Strasbourg, France. ldupuis@unistra.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Acta Neuropathol</MedlineTA><NlmUniqueID>0412041</NlmUniqueID><ISSNLinking>0001-6322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>67382-96-1</RegistryNumber><NameOfSubstance UI="C019463">melanin-concentrating hormone</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009479">Neuropeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000068797">Orexins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Neurol. 2023 Jun;19(6):325</RefSource><PMID Version="1">37147380</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009479" MajorTopicYN="Y">Neuropeptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068797" MajorTopicYN="N">Orexins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004435" MajorTopicYN="N">Eating</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015431" MajorTopicYN="N">Weight Loss</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>DRT received speaker honorary or travel reimbursement from Novartis Pharma AG (Basel, Switzerland), UCB (Brussels, Belgium), and GE Healthcare (Amersham, UK), and collaborated with Novartis Pharma AG (Basel, Switzerland), Probiodrug (Halle (Saale), Germany), GE Healthcare (Amersham, UK), and Janssen Pharmaceutical Companies (Beerse, Belgium). DRT serves in the editorial board of Acta Neuropathologica but was not involved in the handling of this manuscript at any stage. LD reports having sponsored research agreements with Inflectis Bioscience and Cytokinetics. Other authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>11</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37058170</ArticleId><ArticleId IdType="pmc">PMC10175407</ArticleId><ArticleId IdType="doi">10.1007/s00401-023-02569-x</ArticleId><ArticleId IdType="pii">10.1007/s00401-023-02569-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmed RM, Steyn F, Dupuis L. Hypothalamus and weight loss in amyotrophic lateral sclerosis. Handb Clin Neurol. 2021;180:327&#x2013;338. doi: 10.1016/B978-0-12-820107-7.00020-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-820107-7.00020-3</ArticleId><ArticleId IdType="pubmed">34225938</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Massadi O, Dieguez C, Schneeberger M, Lopez M, Schwaninger M, Prevot V, Nogueiras R. Multifaceted actions of melanin-concentrating hormone on mammalian energy homeostasis. Nat Rev Endocrinol. 2021;17:745&#x2013;755. doi: 10.1038/s41574-021-00559-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-021-00559-1</ArticleId><ArticleId IdType="pubmed">34608277</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayer D, Antonucci S, Muller HP, Saad R, Dupuis L, Rasche V, Bockers TM, Ludolph AC, Kassubek J, Roselli F. Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients. Transl Neurodegener. 2021;10:17. doi: 10.1186/s40035-021-00241-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-021-00241-6</ArticleId><ArticleId IdType="pmc">PMC8168014</ArticleId><ArticleId IdType="pubmed">34059131</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergemalm D, Jonsson PA, Graffmo KS, Andersen PM, Brannstrom T, Rehnmark A, Marklund SL. Overloading of stable and exclusion of unstable human superoxide dismutase-1 variants in mitochondria of murine amyotrophic lateral sclerosis models. J Neurosci. 2006;26:4147&#x2013;4154. doi: 10.1523/JNEUROSCI.5461-05.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5461-05.2006</ArticleId><ArticleId IdType="pmc">PMC6673995</ArticleId><ArticleId IdType="pubmed">16624935</ArticleId></ArticleIdList></Reference><Reference><Citation>Berthoud HR, Munzberg H. The lateral hypothalamus as integrator of metabolic and environmental needs: from electrical self-stimulation to opto-genetics. Physiol Behav. 2011;104:29&#x2013;39. doi: 10.1016/j.physbeh.2011.04.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physbeh.2011.04.051</ArticleId><ArticleId IdType="pmc">PMC3131619</ArticleId><ArticleId IdType="pubmed">21549732</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnavion P, Mickelsen L, Fujita A, de Lecea L, Jackson AC. Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour. J Physiol. 2016 doi: 10.1113/JP271946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP271946</ArticleId><ArticleId IdType="pmc">PMC5108896</ArticleId><ArticleId IdType="pubmed">27302606</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H. On the striate area of the human isocortex. A Golgi- and pigmentarchitectonic study. J Comp Neurol. 1976;166:341&#x2013;364. doi: 10.1002/cne.901660305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.901660305</ArticleId><ArticleId IdType="pubmed">1262558</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239&#x2013;259. doi: 10.1007/BF00308809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00308809</ArticleId><ArticleId IdType="pubmed">1759558</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Brettschneider J, Ludolph AC, Lee VM, Trojanowski JQ, Del Tredici K. Amyotrophic lateral sclerosis&#x2013;a model of corticofugal axonal spread. Nat Rev Neurol. 2013;9:708&#x2013;714. doi: 10.1038/nrneurol.2013.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.221</ArticleId><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Feldengut S, Kassubek J, Yilmazer-Hanke D, Del Tredici K. Two histological methods for recognition and study of cortical microinfarcts in thick sections. Eur J Histochem. 2018 doi: 10.4081/ejh.2018.2989.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/ejh.2018.2989</ArticleId><ArticleId IdType="pmc">PMC6334235</ArticleId><ArticleId IdType="pubmed">30572697</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Tredici KD, R&#xfc;b U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson&#x2019;s disease. Neurobiol Aging. 2003;24:197&#x2013;211. doi: 10.1016/S0197-4580(02)00065-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0197-4580(02)00065-9</ArticleId><ArticleId IdType="pubmed">12498954</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Arai K, Del Tredici K, Toledo JB, Robinson JL, Lee EB, Kuwabara S, Shibuya K, Irwin DJ, Fang L, et al. TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol. 2014;128:423&#x2013;437. doi: 10.1007/s00401-014-1299-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1299-6</ArticleId><ArticleId IdType="pmc">PMC4384652</ArticleId><ArticleId IdType="pubmed">24916269</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M, Suh E, Van Deerlin VM, Wood EM, Baek Y, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013;74:20&#x2013;38. doi: 10.1002/ana.23937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski MD, Takei H, Schulz PE, Appel SH, Powell SZ. TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2014;2:171. doi: 10.1186/s40478-014-0171-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-014-0171-1</ArticleId><ArticleId IdType="pmc">PMC4297460</ArticleId><ArticleId IdType="pubmed">25539830</ArticleId></ArticleIdList></Reference><Reference><Citation>Dedeene L, Van Schoor E, Ospitalieri S, Ronisz A, Weishaupt JH, Otto M, Ludolph AC, Scheuerle A, Vandenberghe R, Van Damme P, et al. Dipeptide repeat protein and TDP-43 pathology along the hypothalamic-pituitary axis in C9orf72 and non-C9orf72 ALS and FTLD-TDP cases. Acta Neuropathol. 2020;140:777&#x2013;781. doi: 10.1007/s00401-020-02216-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02216-9</ArticleId><ArticleId IdType="pubmed">32862270</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport J-C, Torny F, Lacoste M, Preux P-M, Couratier P. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegenerative Dis. 2006;2:202&#x2013;207. doi: 10.1159/000089626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000089626</ArticleId><ArticleId IdType="pubmed">16909026</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport JC, Preux PM, Truong CT, Courat L, Vallat JM, Couratier P. Nutritional assessment and survival in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:91&#x2013;96. doi: 10.1080/14660820050515386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820050515386</ArticleId><ArticleId IdType="pubmed">11467055</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999;53:1059&#x2013;1063. doi: 10.1212/WNL.53.5.1059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.53.5.1059</ArticleId><ArticleId IdType="pubmed">10496266</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport JC, Torny F, Lacoste M, Preux PM, Couratier P. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegenerative Dis. 2005;2:202&#x2013;207. doi: 10.1159/000089626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000089626</ArticleId><ArticleId IdType="pubmed">16909026</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, Cypionka J, Ludolph AC. High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: a prospective interventional study. Amyotrophic Lateral Sclerosis Frontotemporal Degeneration. 2013;14:533&#x2013;536. doi: 10.3109/21678421.2013.823999.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.823999</ArticleId><ArticleId IdType="pubmed">23944684</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, K&#xfc;hnlein P, Hendrich C, Kassubek J, Sperfeld AD, Ludolph AC. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol. 2011;258:613&#x2013;617. doi: 10.1007/s00415-010-5805-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5805-z</ArticleId><ArticleId IdType="pubmed">21128082</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, Schuster J, Dreyhaupt J, Witzel S, Weishaupt JH, Kassubek J, Weiland U, Petri S, Meyer T, Grehl T, et al. Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2020;91:1007&#x2013;1009. doi: 10.1136/jnnp-2020-323372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323372</ArticleId><ArticleId IdType="pubmed">32788256</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar JL, Bonnefont-Rousselot D, Bittar R, Seilhean D, Hauw JJ, Lacomblez L, Loeffler JP, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70:1004&#x2013;1009. doi: 10.1212/01.wnl.0000285080.70324.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000285080.70324.27</ArticleId><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, Loeffler JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A. 2004;101:11159&#x2013;11164. doi: 10.1073/pnas.0402026101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Egwuenu EJ, Fong AY, Pilowsky PM. Intrathecal melanin-concentrating hormone reduces sympathetic tone and blocks cardiovascular reflexes. Am J Physiol Regul Integr Comp Physiol. 2012;303:R624&#x2013;632. doi: 10.1152/ajpregu.00215.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00215.2012</ArticleId><ArticleId IdType="pubmed">22814666</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias CF, Sita LV, Zambon BK, Oliveira ER, Vasconcelos LA, Bittencourt JC. Melanin-concentrating hormone projections to areas involved in somatomotor responses. J Chem Neuroanat. 2008;35:188&#x2013;201. doi: 10.1016/j.jchemneu.2007.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2007.10.002</ArticleId><ArticleId IdType="pubmed">18065197</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldengut S, Del Tredici K, Braak H. Paraffin sections of 70&#x2013;100 mum: a novel technique and its benefits for studying the nervous system. J Neurosci Methods. 2013;215:241&#x2013;244. doi: 10.1016/j.jneumeth.2013.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneumeth.2013.03.010</ArticleId><ArticleId IdType="pubmed">23537935</ArticleId></ArticleIdList></Reference><Reference><Citation>Fellmann D, Risold PY, Bahjaoui M, Compagnone N, Bresson JL, Clavequin MC, Cardot J, Gouget A, Lenys D, Bugnon C. Morphofunctional studies on the neurons producing melanin-concentrating hormone. Ann N Y Acad Sci. 1993;680:511&#x2013;516. doi: 10.1111/j.1749-6632.1993.tb19724.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.1993.tb19724.x</ArticleId><ArticleId IdType="pubmed">8512225</ArticleId></ArticleIdList></Reference><Reference><Citation>Flatt JP. Importance of nutrient balance in body weight regulation. Diabetes Metab Rev. 1988;4:571&#x2013;581. doi: 10.1002/dmr.5610040603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmr.5610040603</ArticleId><ArticleId IdType="pubmed">3065010</ArticleId></ArticleIdList></Reference><Reference><Citation>Funalot B, Desport JC, Sturtz F, Camu W, Couratier P (2008) High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler: 1&#x2013;5</Citation><ArticleIdList><ArticleId IdType="pubmed">18792852</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabery S, Ahmed RM, Caga J, Kiernan MC, Halliday GM, Petersen A. Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis. Neuropathology Applied Neurobio. 2021 doi: 10.1111/nan.12709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12709</ArticleId><ArticleId IdType="pubmed">33755993</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo V, Wark PA, Jenab M, Pearce N, Brayne C, Vermeulen R, Andersen PM, Hallmans G, Kyrozis A, Vanacore N, et al. Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort. Neurology. 2013;80:829&#x2013;838. doi: 10.1212/WNL.0b013e3182840689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182840689</ArticleId><ArticleId IdType="pmc">PMC3598455</ArticleId><ArticleId IdType="pubmed">23390184</ArticleId></ArticleIdList></Reference><Reference><Citation>Glick M, Segal-Lieberman G, Cohen R, Kronfeld-Schor N. Chronic MCH infusion causes a decrease in energy expenditure and body temperature, and an increase in serum IGF-1 levels in mice. Endocrine. 2009;36:479&#x2013;485. doi: 10.1007/s12020-009-9252-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-009-9252-5</ArticleId><ArticleId IdType="pubmed">19859841</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorges M, Vercruysse P, Muller HP, Huppertz HJ, Rosenbohm A, Nagel G, Weydt P, Petersen A, Ludolph AC, Kassubek J, et al. Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2017;88:1033&#x2013;1041. doi: 10.1136/jnnp-2017-315795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315795</ArticleId><ArticleId IdType="pubmed">28596251</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito M, Gomori A, Ishihara A, Oda Z, Mashiko S, Matsushita H, Yumoto M, Ito M, Sano H, Tokita S, et al. Characterization of MCH-mediated obesity in mice. Am J Physiol Endocrinol Metab. 2003;284:E940&#x2013;945. doi: 10.1152/ajpendo.00529.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00529.2002</ArticleId><ArticleId IdType="pubmed">12554598</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaarsma D, Haasdijk ED, Grashorn JA, Hawkins R, van Duijn W, Verspaget HW, London J, Holstege JC. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol Dis. 2000;7:623&#x2013;643. doi: 10.1006/nbdi.2000.0299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2000.0299</ArticleId><ArticleId IdType="pubmed">11114261</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaarsma D, Rognoni F, van Duijn W, Verspaget HW, Haasdijk ED, Holstege JC. CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations. Acta Neuropathol (Berl) 2001;102:293&#x2013;305. doi: 10.1007/s004010100399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010100399</ArticleId><ArticleId IdType="pubmed">11603803</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon JY, Bradley RL, Kokkotou EG, Marino FE, Wang X, Pissios P, Maratos-Flier E. MCH-/- mice are resistant to aging-associated increases in body weight and insulin resistance. Diabetes. 2006;55:428&#x2013;434. doi: 10.2337/diabetes.55.02.06.db05-0203.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.55.02.06.db05-0203</ArticleId><ArticleId IdType="pubmed">16443777</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L, Bence KK, Sandesara I, Andreux P, Auwerx J, Ishibashi J, Seale P, Kalb RG. Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosis. Hum Mol Genet. 2014 doi: 10.1093/hmg/ddu214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu214</ArticleId><ArticleId IdType="pmc">PMC4140473</ArticleId><ArticleId IdType="pubmed">24833719</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Ren Q, Gong G, Sun Y, Zhao B, Ma X, Zhang N, Zhong S, Lin Y, Wang W, et al. Hypothalamic subregion abnormalities are related to body mass index in patients with sporadic amyotrophic lateral sclerosis. J Neurol. 2021 doi: 10.1007/s00415-021-10900-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10900-3</ArticleId><ArticleId IdType="pubmed">34779889</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, Dorst J, Dreyhaupt J, Weishaupt JH, Kassubek J, Weiland U, Meyer T, Petri S, Hermann A, Emmer A, et al. Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis. Ann Neurol. 2020;87:206&#x2013;216. doi: 10.1002/ana.25661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25661</ArticleId><ArticleId IdType="pubmed">31849093</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwig DS, Mountjoy KG, Tatro JB, Gillette JA, Frederich RC, Flier JS, Maratos-Flier E. Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus. Am J Physiol. 1998;274:E627&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pubmed">9575823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwig DS, Tritos NA, Mastaitis JW, Kulkarni R, Kokkotou E, Elmquist J, Lowell B, Flier JS, Maratos-Flier E. Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J Clin Invest. 2001;107:379&#x2013;386. doi: 10.1172/JCI10660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI10660</ArticleId><ArticleId IdType="pmc">PMC199192</ArticleId><ArticleId IdType="pubmed">11160162</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Desport JC, Kajeu P, Jesus P, Nicolaud B, Nicol M, Preux PM, Couratier P. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry. 2011;82:628&#x2013;634. doi: 10.1136/jnnp.2010.211474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.211474</ArticleId><ArticleId IdType="pubmed">21097551</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27:1918&#x2013;1929. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Mickelsen LE, Bolisetty M, Chimileski BR, Fujita A, Beltrami EJ, Costanzo JT, Naparstek JR, Robson P, Jackson AC. Single-cell transcriptomic analysis of the lateral hypothalamic area reveals molecularly distinct populations of inhibitory and excitatory neurons. Nat Neurosci. 2019;22:642&#x2013;656. doi: 10.1038/s41593-019-0349-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0349-8</ArticleId><ArticleId IdType="pmc">PMC7043322</ArticleId><ArticleId IdType="pubmed">30858605</ArticleId></ArticleIdList></Reference><Reference><Citation>Mina AI, LeClair RA, LeClair KB, Cohen DE, Lantier L, Banks AS. CalR: a web-based analysis tool for indirect calorimetry experiments. Cell Metab. 2018 doi: 10.1016/j.cmet.2018.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2018.06.019</ArticleId><ArticleId IdType="pmc">PMC6170709</ArticleId><ArticleId IdType="pubmed">30017358</ArticleId></ArticleIdList></Reference><Reference><Citation>Morton GJ, Meek TH, Schwartz MW. Neurobiology of food intake in health and disease. Nat Rev Neurosci. 2014;15:367&#x2013;378. doi: 10.1038/nrn3745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3745</ArticleId><ArticleId IdType="pmc">PMC4076116</ArticleId><ArticleId IdType="pubmed">24840801</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura M, Bieniek KF, Lin WL, Graff-Radford NR, Murray ME, Castanedes-Casey M, Desaro P, Baker MC, Rutherford NJ, Robertson J, et al. A truncating SOD1 mutation, p.Gly141X, is associated with clinical and pathologic heterogeneity, including frontotemporal lobar degeneration. Acta Neuropathol. 2015;130:145&#x2013;157. doi: 10.1007/s00401-015-1431-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1431-2</ArticleId><ArticleId IdType="pmc">PMC5039014</ArticleId><ArticleId IdType="pubmed">25917047</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo ST, van Eijk RPA, Chachay V, van den Berg LH, McCombe PA, Henderson RD, Steyn FJ, (2019) Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis and frontotemporal degeneration 20: 497-505 10.1080/21678421.2019.1621346</Citation><ArticleIdList><ArticleId IdType="pubmed">31144522</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Reilly EJ, Wang H, Weisskopf MG, Fitzgerald KC, Falcone G, McCullough ML, Thun M, Park Y, Kolonel LN, Ascherio A. Premorbid body mass index and risk of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis Frontotemporal Degeneration. 2013;14:205&#x2013;211. doi: 10.3109/21678421.2012.735240.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2012.735240</ArticleId><ArticleId IdType="pmc">PMC3615420</ArticleId><ArticleId IdType="pubmed">23134505</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve. 2011;44:20&#x2013;24. doi: 10.1002/mus.22114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22114</ArticleId><ArticleId IdType="pmc">PMC4441750</ArticleId><ArticleId IdType="pubmed">21607987</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamiuc L, Schlagowski A, Ngo ST, Vernay A, Dirrig-Grosch S, Henriques A, Boutillier AL, Zoll J, Echaniz-Laguna A, Loeffler JP, et al. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol Med. 2015;7:526&#x2013;546. doi: 10.15252/emmm.201404433.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201404433</ArticleId><ArticleId IdType="pmc">PMC4492815</ArticleId><ArticleId IdType="pubmed">25820275</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter RS, Rosenbohm A, Dupuis L, Brehme T, Kassubek J, Rothenbacher D, Nagel G, Ludolph AC. Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia. Eur J Epidemiol. 2017;32:901&#x2013;908. doi: 10.1007/s10654-017-0318-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-017-0318-z</ArticleId><ArticleId IdType="pubmed">28975435</ArticleId></ArticleIdList></Reference><Reference><Citation>Potter LE, Burgess CR. The melanin-concentrating hormone system as a target for the treatment of sleep disorders. Front Neurosci. 2022 doi: 10.3389/fnins.2022.952275.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.952275</ArticleId><ArticleId IdType="pmc">PMC9513178</ArticleId><ArticleId IdType="pubmed">36177357</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 1995;92:689&#x2013;693. doi: 10.1073/pnas.92.3.689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.3.689</ArticleId><ArticleId IdType="pmc">PMC42685</ArticleId><ArticleId IdType="pubmed">7846037</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaricamazza S, Salvatori I, Amadio S, Nesci V, Torcinaro A, Giacovazzo G, Primiano A, Gloriani M, Candelise N, Pieroni L, et al. Repurposing of Trimetazidine for amyotrophic lateral sclerosis: a study in SOD1(G93A) mice. Br J Pharmacol. 2021 doi: 10.1111/bph.15738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15738</ArticleId><ArticleId IdType="pmc">PMC9305494</ArticleId><ArticleId IdType="pubmed">34783031</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaricamazza S, Salvatori I, Giacovazzo G, Loeffler JP, Rene F, Rosina M, Quessada C, Proietti D, Heil C, Rossi S, et al. Skeletal-muscle metabolic reprogramming in ALS-SOD1(G93A) mice predates disease onset and is a promising therapeutic target. iScience. 2020 doi: 10.1016/j.isci.2020.101087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101087</ArticleId><ArticleId IdType="pmc">PMC7200935</ArticleId><ArticleId IdType="pubmed">32371370</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J, El Oussini H, Mersmann S, Drenner K, Wagner M, Sun Y, Allmeroth K, Dieterle S, Sinniger J, Dirrig-Grosch S, et al. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 2017;133:887&#x2013;906. doi: 10.1007/s00401-017-1687-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1687-9</ArticleId><ArticleId IdType="pmc">PMC5427169</ArticleId><ArticleId IdType="pubmed">28243725</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J, Oussini HE, Mersmann S, Drenner K, Wagner M, Sun Y, Allmeroth K, Dieterle S, Sinniger J, Dirrig-Grosch S, et al. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:887&#x2013;906. doi: 10.1007/s00401-017-1687-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1687-9</ArticleId><ArticleId IdType="pmc">PMC5427169</ArticleId><ArticleId IdType="pubmed">28243725</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J, Sanjuan-Ruiz I, Kan V, Megat S, De Rossi P, Dieterle S, Cassel R, Jamet M, Kessler P, Wiesner D, et al. Cytoplasmic FUS triggers early behavioral alterations linked to cortical neuronal hyperactivity and inhibitory synaptic defects. Nat Commun. 2021;12:3028. doi: 10.1038/s41467-021-23187-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23187-9</ArticleId><ArticleId IdType="pmc">PMC8140148</ArticleId><ArticleId IdType="pubmed">34021132</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J, Sendscheid O, El Oussini H, Jambeau M, Sun Y, Mersmann S, Wagner M, Dieterle S, Sinniger J, Dirrig-Grosch S, et al. Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss. EMBO J. 2016;35:1077&#x2013;1097. doi: 10.15252/embj.201592559.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201592559</ArticleId><ArticleId IdType="pmc">PMC4868956</ArticleId><ArticleId IdType="pubmed">26951610</ArticleId></ArticleIdList></Reference><Reference><Citation>Segal-Lieberman G, Bradley RL, Kokkotou E, Carlson M, Trombly DJ, Wang X, Bates S, Myers MG, Jr, Flier JS, Maratos-Flier E. Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype. Proc Natl Acad Sci U S A. 2003;100:10085&#x2013;10090. doi: 10.1073/pnas.1633636100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1633636100</ArticleId><ArticleId IdType="pmc">PMC187774</ArticleId><ArticleId IdType="pubmed">12897241</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimada M, Tritos NA, Lowell BB, Flier JS, Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature. 1998;396:670&#x2013;674. doi: 10.1038/25341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/25341</ArticleId><ArticleId IdType="pubmed">9872314</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn JW. Network of hypothalamic neurons that control appetite. BMB Rep. 2015;48:229&#x2013;233. doi: 10.5483/bmbrep.2015.48.4.272.</Citation><ArticleIdList><ArticleId IdType="doi">10.5483/bmbrep.2015.48.4.272</ArticleId><ArticleId IdType="pmc">PMC4436859</ArticleId><ArticleId IdType="pubmed">25560696</ArticleId></ArticleIdList></Reference><Reference><Citation>Speakman JR. Measuring energy metabolism in the mouse - theoretical, practical, and analytical considerations. Front Physiol. 2013;4:34. doi: 10.3389/fphys.2013.00034.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2013.00034</ArticleId><ArticleId IdType="pmc">PMC3596737</ArticleId><ArticleId IdType="pubmed">23504620</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn FJ, Ioannides ZA, van Eijk RPA, Heggie S, Thorpe KA, Ceslis A, Heshmat S, Henders AK, Wray NR, van den Berg LH, et al. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J Neurol Neurosurg Psychiatry. 2018;89:1016&#x2013;1023. doi: 10.1136/jnnp-2017-317887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317887</ArticleId><ArticleId IdType="pmc">PMC6166607</ArticleId><ArticleId IdType="pubmed">29706605</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn FJ, Li R, Kirk SE, Tefera TW, Xie TY, Tracey TJ, Kelk D, Wimberger E, Garton FC, Roberts L, et al. Altered skeletal muscle glucose-fatty acid flux in amyotrophic lateral sclerosis. Brain Commun. 2020 doi: 10.1093/braincomms/fcaa154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa154</ArticleId><ArticleId IdType="pmc">PMC7677608</ArticleId><ArticleId IdType="pubmed">33241210</ArticleId></ArticleIdList></Reference><Reference><Citation>Thal DR, Rub U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58:1791&#x2013;1800. doi: 10.1212/wnl.58.12.1791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.58.12.1791</ArticleId><ArticleId IdType="pubmed">12084879</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschop MH, Speakman JR, Arch JR, Auwerx J, Bruning JC, Chan L, Eckel RH, Farese RV, Jr, Galgani JE, Hambly C, et al. A guide to analysis of mouse energy metabolism. Nat Methods. 2011;9:57&#x2013;63. doi: 10.1038/nmeth.1806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1806</ArticleId><ArticleId IdType="pmc">PMC3654855</ArticleId><ArticleId IdType="pubmed">22205519</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002 doi: 10.1186/Gb-2002-3-7-Research0034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/Gb-2002-3-7-Research0034</ArticleId><ArticleId IdType="pmc">PMC126239</ArticleId><ArticleId IdType="pubmed">12184808</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercruysse P, Sinniger J, El Oussini H, Scekic-Zahirovic J, Dieterle S, Dengler R, Meyer T, Zierz S, Kassubek J, Fischer W, et al. Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis. Brain. 2016;139:1106&#x2013;1122. doi: 10.1093/brain/aww004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww004</ArticleId><ArticleId IdType="pubmed">26984187</ArticleId></ArticleIdList></Reference><Reference><Citation>Viale A, Courseaux A, Presse F, Ortola C, Breton C, Jordan D, Nahon JL. Structure and expression of the variant melanin-concentrating hormone genes: only PMCHL1 is transcribed in the developing human brain and encodes a putative protein. Mol Biol Evol. 2000;17:1626&#x2013;1640. doi: 10.1093/oxfordjournals.molbev.a026262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.molbev.a026262</ArticleId><ArticleId IdType="pubmed">11070051</ArticleId></ArticleIdList></Reference><Reference><Citation>Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol. 1949;109:1&#x2013;9. doi: 10.1113/jphysiol.1949.sp004363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1949.sp004363</ArticleId><ArticleId IdType="pmc">PMC1392602</ArticleId><ArticleId IdType="pubmed">15394301</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng HJ, van Veenhuijzen K, van der Spek RA, Peters S, Visser AE, van Rheenen W, Veldink JH, van den Berg LH. Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control study. Lancet Neurol. 2021;20:373&#x2013;384. doi: 10.1016/S1474-4422(21)00042-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00042-9</ArticleId><ArticleId IdType="pubmed">33894192</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills AM, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP, Brooks B, Gelinas D, Mitsumoto H, Mozaffar T, et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet. 2014 doi: 10.1016/S0140-6736(14)60222-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60222-1</ArticleId><ArticleId IdType="pmc">PMC4176708</ArticleId><ArticleId IdType="pubmed">24582471</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo GS, Heisler LK. Unraveling the brain regulation of appetite: lessons from genetics. Nat Neurosci. 2012;15:1343&#x2013;1349. doi: 10.1038/nn.3211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3211</ArticleId><ArticleId IdType="pubmed">23007189</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmazer-Hanke D, Mayer T, Muller HP, Neugebauer H, Abaei A, Scheuerle A, Weis J, Forsberg KME, Althaus K, Meier J, et al. Histological correlates of postmortem ultra-high-resolution single-section MRI in cortical cerebral microinfarcts. Acta Neuropathol Commun. 2020;8:33. doi: 10.1186/s40478-020-00900-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00900-1</ArticleId><ArticleId IdType="pmc">PMC7071593</ArticleId><ArticleId IdType="pubmed">32169123</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmazer-Hanke DM, Wolf HK, Schramm J, Elger CE, Wiestler OD, Blumcke I. Subregional pathology of the amygdala complex and entorhinal region in surgical specimens from patients with pharmacoresistant temporal lobe epilepsy. J Neuropathol Exp Neurol. 2000;59:907&#x2013;920. doi: 10.1093/jnen/59.10.907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/59.10.907</ArticleId><ArticleId IdType="pubmed">11079781</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>